Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Cerini

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
AIDS Research and Human Retroviruses|February 9, 2017
Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal LavageFabrice Cerini, Robin Offord, Ian McGowan, et al.
The Journal of Biological Chemistry|October 12, 2018
Rapid and low-cost multiplex synthesis of chemokine analogsMarianne Paolini-Bertrand, Fabrice Cerini, Elsa Martins, et al.
Methods in Enzymology|February 29, 2016
Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage DisplayKarim Dorgham, Fabrice Cerini, Hubert Gaertner, et al.
Bioconjugate Chemistry|May 18, 2011
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticlesHubert F Gaertner, Fabrice Cerini, Arun Kamath, et al.
Plos One|July 16, 2015
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?Sabrina Pagano, Hubert Gaertner, Fabrice Cerini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Chemokine analogues show suitable stability for development as microbicidesFabrice Cerini, Alan Landay, Carolyne Gichinga, et al.
Journal of Virology|May 28, 2003
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokinesOliver Hartley, Karim Dorgham, Danielle Perez-Bercoff, et al.
Protein Engineering, Design & Selection : PEDS|January 8, 2008
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4Hubert Gaertner, Olivier Lebeau, Irène Borlat, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicideHubert Gaertner, Fabrice Cerini, Jean-Michel Escola, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2004
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitorsOliver Hartley, Hubert Gaertner, Jill Wilken, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
AIDS Research and Human Retroviruses|February 9, 2017
Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal LavageFabrice Cerini, Robin Offord, Ian McGowan, et al.
The Journal of Biological Chemistry|October 12, 2018
Rapid and low-cost multiplex synthesis of chemokine analogsMarianne Paolini-Bertrand, Fabrice Cerini, Elsa Martins, et al.
Methods in Enzymology|February 29, 2016
Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage DisplayKarim Dorgham, Fabrice Cerini, Hubert Gaertner, et al.
Bioconjugate Chemistry|May 18, 2011
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticlesHubert F Gaertner, Fabrice Cerini, Arun Kamath, et al.
Plos One|July 16, 2015
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?Sabrina Pagano, Hubert Gaertner, Fabrice Cerini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Chemokine analogues show suitable stability for development as microbicidesFabrice Cerini, Alan Landay, Carolyne Gichinga, et al.
Journal of Virology|May 28, 2003
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokinesOliver Hartley, Karim Dorgham, Danielle Perez-Bercoff, et al.
Protein Engineering, Design & Selection : PEDS|January 8, 2008
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4Hubert Gaertner, Olivier Lebeau, Irène Borlat, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicideHubert Gaertner, Fabrice Cerini, Jean-Michel Escola, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2004
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitorsOliver Hartley, Hubert Gaertner, Jill Wilken, et al.
Pageof 2